IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
about
Obesity and low-grade inflammation increase plasma follistatin-like 3 in humans.Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.Expression of cartilage glycoprotein 39 in peripheral blood monocytes of septic rat and its role in TLR 4-NF-κB signaling pathways.Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjectsCancer risk by combined levels of YKL-40 and C-reactive protein in the general populationIncreased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon CancerThe impact of acute aerobic exercise on chitinase 3-like protein 1 and intelectin-1 expression in obesity.YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII StudyThe tumor microenvironment promotes cancer progression and cell migration.Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironmentPrognostic Biomarkers for Hodgkin Lymphoma.Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.Plasma YKL-40 in Inuit and Danes.Novel inflammatory marker in dialysis patients: YKL-40.Plasma YKL-40: a potential biomarker for psoriatic arthritis?Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and valiInteractions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.The Effects of Ferulic Acid Against Oxidative Stress and Inflammation in Formaldehyde-Induced Hepatotoxicity.Serum YKL-40 and gestational diabetes - an observational cohort study.The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation.Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis
P2860
Q33930386-7B8D536D-12E6-464D-8184-F4FF1ED00477Q34806348-72035FC7-8EE4-43A5-835E-2D628C29071BQ35021964-65584A77-53C7-4898-9F92-EB407C6DAB37Q35077055-E6AE0C68-A9B6-4B1F-B078-0FF81C3B74A5Q35104023-D958D0CB-BDCE-44B2-9CA1-1BC365A41BAAQ35480620-C574BBE7-20B1-47AE-9CE6-99596D294A76Q35557987-8DDAC2EC-D994-4D2A-AD74-281E45AB3798Q35653750-EBA319AA-7B8E-4CF6-8C1B-8433D0AC4725Q36128631-8419EF88-CED6-4617-ACDE-DCA5DAD61EC3Q37071517-4DF1FF50-10DA-4F1D-8CE2-86C1D8FC4C34Q37482262-F50F6C63-2ACF-4233-BFE7-46C1D316E310Q37548804-F2FE51D6-B195-49C7-B448-6BEA97FE572CQ37706031-1880EB6A-8D8A-4832-99C7-B80E14CF460DQ38285949-44216A27-2EA2-47E2-9CE8-197579DAF548Q38588503-C1112A00-2516-46E9-BEA3-FEC082932042Q41523077-EC44C63D-944E-4C40-9FE0-8A5807D99DE7Q43834139-F979140F-7877-436F-94BF-50005D27F540Q45919537-411F8F9D-A353-440B-8528-4138AABCA26DQ46103273-584A3F9C-D961-488F-B656-58F817BEE5A8Q46359710-8A2E39F6-6623-4DE6-9A02-CEC82E5E896FQ47325932-6D8EA5E5-A038-45D8-A67A-F4783775A585Q47562955-5A86E01F-A5A0-4CC1-8C3D-D31140D064ADQ50588462-438ADC11-35C6-4CB8-A79C-195EEAC75CBFQ51516824-49DF27D1-1F7A-4619-B96C-AA12CEDC7DB8Q51617105-0CB289EC-5411-4808-9C5F-59A6397A82F2Q53374376-B45FC6F4-59E0-4DA2-9646-89F81C1BAB4CQ58122618-60751BF4-7B0E-4221-8FF9-C5B060239A66
P2860
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@ast
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en-gb
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@nl
type
label
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@ast
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en-gb
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@nl
prefLabel
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@ast
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en-gb
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@nl
P2093
P921
P3181
P1433
P1476
IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
@en
P2093
Anders R Nielsen
Julia S Johansen
Karen S Krabbe
P3181
P356
10.1016/J.CYTO.2011.03.014
P407
P577
2011-07-01T00:00:00Z